NCT00001048View on ClinicalTrials.gov

Comparison of Anti HIV Drugs Used Alone or in Combination With Cytosine Arabinoside to Treat Progressive Multifocal Leukoencephalopathy (PML) in HIV-Infected Patients

PHASE2CompletedINTERVENTIONAL
Enrollment

90

Participants

Timeline

Start Date

Not specified

Study Completion Date

April 30, 1997

Conditions
HIV InfectionsLeukoencephalopathy, Progressive Multifocal
Interventions
DRUG

Filgrastim

DRUG

Cytarabine

DRUG

Zidovudine

DRUG

Zalcitabine

DRUG

Didanosine

Trial Locations (9)

14642

Univ. of Rochester ACTG CRS, Rochester

21287

Johns Hopkins Adult AIDS CRS, Baltimore

60611

Northwestern University CRS, Chicago

80262

University of Colorado Hospital CRS, Aurora

275997215

Unc Aids Crs, Chapel Hill

331361013

Univ. of Miami AIDS CRS, Miami

981224304

University of Washington AIDS CRS, Seattle

02114

Massachusetts General Hospital ACTG CRS, Boston

Unknown

Washington U CRS, St Louis

Sponsors
All Listed Sponsors
collaborator

Bristol-Myers Squibb

INDUSTRY

collaborator

Upjohn

INDUSTRY

lead

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

NCT00001048 - Comparison of Anti HIV Drugs Used Alone or in Combination With Cytosine Arabinoside to Treat Progressive Multifocal Leukoencephalopathy (PML) in HIV-Infected Patients | Biotech Hunter | Biotech Hunter